SCHEMBL21147833

SCHEMBL21147833

CC(C)P1OCC2CCCN21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22260415 0.94
SCHEMBL19375719 0.74
SCHEMBL19375422 0.74
SCHEMBL23917960 0.71
SCHEMBL2408898 0.71
SCHEMBL2411906 0.71
SCHEMBL24052101 0.71
SCHEMBL20806118 0.69
SCHEMBL12279592 0.69
SCHEMBL12279504 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220401467-A1 OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2022-12-22 US disclosed
WO-2022147223-A2 2'-MODIFIED NUCLEOSIDE BASED OLIGONUCLEOTIDE PRODRUGS ALNYLAM PHARMACEUTICALS, INC. (US) 2022-07-07 WO disclosed
US-11013757-B2 Oligonucleotides, compositions and methods thereof WAVE LIFE SCIENCES LTD. (SG) 2021-05-25 US disclosed
US-20190209604-A1 OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2019-07-11 US disclosed